SCHEDULE 13G

Company

Dianthus Therapeutics, Inc. /DE/

Filed

June 10, 2019

Accession Number

0001144204-19-030464

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →